Skip to content

Vivani Medical VANI Operating Income

Operating Income at other companies

Amgen logo
AmgenAMGN
$2.67B+126%
Altimmune logo
AltimmuneALT
-$24.24M-11.1%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$164.13M-196%
Wave Life Sciences logo
Wave Life SciencesWVE
-$31.3M+37.2%
Prime Medicine logo
Prime MedicinePRME
-$50.65M+3.3%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$43.78M-15.8%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+37.8%
Enterprise value$106.17M+17.4%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's operating income?
Vivani Medical (VANI) reported operating income of -$6.82M in Q1 2026.
How has Vivani Medical's operating income changed year-over-year?
Vivani Medical's operating income decreased by 4.0% year-over-year, from -$6.56M to -$6.82M.
What is the long-term trend for Vivani Medical's operating income?
Over 4 years (2021 to 2025), Vivani Medical's operating income has grown at a 29.1% compound annual growth rate (CAGR), from -$9.92M to -$27.55M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.